Research Articles | Page 5 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuria Sep 2024 American Journal of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
A growing panoply of options for patients with paroxysmal nocturnal hemoglobinuria Sep 2024 American Journal of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
A growing panoply of options for patients with paroxysmal nocturnal hemoglobinuria Sep 2024 American Journal of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Advances in the management of higher-risk myelodysplastic syndromes: future prospects Sep 2024 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
SOHO State of the Art Updates and Next Questions: An Update on Higher Risk Myelodysplastic Syndromes Sep 2024 Clinical Lymphoma, Myeloma & Leukemia Myelodysplastic Syndromes (MDS)
Clinical Outcomes and Healthcare Resource Utilization for Patients With Lower-Risk Myelodysplastic Syndromes Treated With Erythropoiesis-Stimulating Agents Sep 2024 Clinical Lymphoma, Myeloma & Leukemia Myelodysplastic Syndromes (MDS)
Allogeneic Hematopoietic Cell Transplantation for the Treatment of Severe Aplastic Anemia: Evidence-Based Guidelines From the American Society for Transplantation and Cellular Therapy Sep 2024 Transplantation and Cellular Therapy Myelodysplastic Syndromes (MDS)
Oral complement factor D inhibitor danicopan for paroxysmal nocturnal hemoglobinuria Sep 2024 Expert Review of Clinical Pharmacology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Myelodysplastic Syndromes Treatment (PDQ®): Health Professional Version Sep 2024 PDQ Cancer Information Summaries Myelodysplastic Syndromes (MDS)
How we diagnose Myelodysplastic syndromes Sep 2024 Frontiers in Oncology Myelodysplastic Syndromes (MDS)